arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

WEST PHARMACEUTICAL SERVICES INC

WST
$353.93 ▲ +5.66 (+1.63%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
68 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
79
Health
Good
Bullish
auto_awesome

Analytical Summary

WEST PHARMACEUTICAL SERVICES INC shows strong fundamentals with top-quartile Return on Common Equity (%) and Profit Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $25.1B
Dividend Yield 0.06%
Revenue Growth 13.8%
Op. Margin 20.5%
ROIC 4.6%
FCF / Share $1.14
Trailing P/E 163.1x
Price / Book 8.3x
FCF Yield 0.3%
Debt / Equity 0.07
info Valuation on last close. End-of-day price, Aug 7, 2026.

68-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$872.30M
↑ +13.8%
Net Income Profit after all expenses
$138.80M
↑ +54.6%
Operating Margin Operating profit as % of sales
20.5%
↓ -2.0% 74th
FCF / Share Free cash flow per share
$1.14
↑ +74.1%
Long-Term Debt Long-term obligations
$202.90M
— 0.0%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
  • Profit Margin (%)Profit Margin (%) is in the top quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
75
Returns
81
Financial Health
89
Cash Quality
63

Dividend History

Dividend / share · sourced from SEC filings
$0.86 Latest / share
+4.9% YoY
+7.0% 12-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 68 quarters